EPO Patents = 4

Forward Citations = 3

Loading Chart...

10 inventors (with patents filed for the assignee):

Matthew Rein Scholz (3 out of 6 patents)

Eric J Herbig (3 out of 3 patents)

Mei Xu (2 out of 2 patents)

4. R Scott McIvor (1 out of 10 patents)

5. Perry B Hackett (1 out of 6 patents)

6. Jason Bell (1 out of 1 patent)

7. Myra Christine Urness-Rusten (1 out of 1 patent)

8. Elena Aronovich (1 out of 1 patent)

9. David W Hunter (1 out of 10 patents)

10. Rian De Laat (0 patent)

11. R Scott Mcivor (0 patent)

4 patents: Sort by Forward Citations

1. 11352603 - Methods for in vitro memory B cell differentiation and transduction with VSV-G pseudotyped viral vectors (2022-06-07),

2. 11103582 - Method to achieve extended expression of DNA infused into liver (2021-08-31),

3. 10240125 - Methods for in vitro memory B cell differentiation and transduction with VSV-G pseudotyped viral vectors (2019-03-26),

4. 9074223 - Vectors and methods for transducing B cells (2015-07-07),

Company Overview

Immusoft Corporation is a biotechnology company that specializes in developing novel gene therapy solutions. The company focuses on using its proprietary technology to reprogram B cells to produce therapeutic proteins within the body, offering potential treatments for a wide range of diseases. Immusoft's innovative approach has the potential to revolutionize the field of gene therapy and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#423 in Seattle, WA

#1,464 in Washington

#60,671 in US

Seattle, WA, United States of America

Immusoft Corporation

Forward Citations = 3

10 inventors:

Matthew Rein Scholz (3 out of 6 patents)

Eric J Herbig (3 out of 3 patents)

Mei Xu (2 out of 2 patents)

4. R Scott McIvor (1 out of 10 patents)

5. Perry B Hackett (1 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immusoft Corporation. Retrieved from https://idiyas.com/company/immusoft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]